MeiraGTx Holdings (MGTX) Revenue (2019 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Revenue came in at $75.4 million in Q4 2025, up 252.33% YoY from $21.4 million in Q4 2024, and up 18281.46% on a QoQ basis from $410000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Revenue (2019 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 7 years of Revenue data on file, last reported at $75.4 million in Q4 2025.
- Quarterly Revenue rose 252.33% year-over-year to $75.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $100.9 million (up 203.06% YoY) and the FY2025 annual result came in at $81.4 million, up 144.57% from the prior year.
- Revenue climbed to $75.4 million in Q4 2025, from $410000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $75.4 million in Q4 2025 to a low of -$5.3 million in Q4 2022.
- A 5-year average of $9.5 million and a median of $4.8 million in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue plunged 125.13% — and 2025, when it soared 1208.87%.
- Tracing MGTX's Revenue over 5 years: stood at $21.0 million in 2021, then sank by 125.13% to -$5.3 million in 2022, then soared by 138.58% to $2.0 million in 2023, then jumped by 948.53% to $21.4 million in 2024, then jumped by 252.33% to $75.4 million in 2025.
- The last three Revenue figures came in at $75.4 million (Q4 2025), $410000.0 (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 321.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 321.43 Mn |
| Dec 31, 2025 | 75.36 Mn |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 3.69 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 21.39 Mn |
| Sep 30, 2024 | 10.91 Mn |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 3.33 Mn |
| Dec 31, 2022 | -5.29 Mn |
| Sep 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 10.76 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 21.04 Mn |
| Sep 30, 2021 | 6.95 Mn |
| Jun 30, 2021 | 5.12 Mn |